Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05745025 Recruiting - Clinical trials for Complex Regional Pain Syndrome Type I

rTMS and Rehabilitation for Individuals With CRPS Type 1

Start date: February 28, 2023
Phase: N/A
Study type: Interventional

Subjects with complex regional pain syndrome (CRPS) Type 1 will be randomized to receive repeated transcranial magnetic stimulation (rTMS) followed by rehabilitation or sham rTMS followed by rehabilitation. Treatment will last for 4 weeks, with the first week including 4 rTMS treatments and 2 rehabilitation treatments. Subsequent weeks will include 2 rTMS treatments followed by 2 rehabilitation treatments. Outcome measures will include pain ratings, PROMIS questionnaires, global rating of change, and grip strength or 1 repetition maximum leg press.

NCT ID: NCT05744843 Recruiting - Clinical trials for Post Thrombotic Syndrome

Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome

SEvERe-PTS
Start date: September 5, 2023
Phase: N/A
Study type: Interventional

The goal of this pilot study and randomised control trial is to compare a smartphone-based exercise programme to deep venous stenting in patients with Post Thrombotic Syndrome. The main questions it aims to answer are: - Is exercise as effective as stenting in these patients? - What type of exercise is useful in these patients? - Can exercise be used to improve the results from surgery? Participants will be split into two groups at random. They will complete a smartphone-based exercise programme or have a deep venous stent. They will do the following tests before and after. - Exercise testing - Calf muscle strength and function tests - Ultrasound of the deep veins - Quality of life questionnaires - Clinical assessment of their disease They will be compared to healthy volunteers in the pilot study. Investigators will compare exercise to stenting to see if it improves symptoms in these patients. The pilot study will help decide how many patients are needed and what exercise tests will be used for the Randomised control trial.

NCT ID: NCT05744258 Recruiting - Clinical trials for Irritable Bowel Syndrome

The Value of Bio-electrical Impedance Analysis in Irritable Bowel Syndrome

BIA-IBS
Start date: August 22, 2022
Phase: N/A
Study type: Interventional

The study aim is to investigate the Bio-electrical Impedance (BIA) parameters in general, and phase angle (PhA) in particular in Irritable bowel syndrome (IBS) patients and to compare these with values from healthy controls, while assessing the relationship with other confounding parameters in IBS: psychological parameters, physical activity, dietary pattern (with special interest in FODMAP intake). In a second phase, the evolution of the BIA parameters will be analyzed according to response to therapy.

NCT ID: NCT05742776 Recruiting - Clinical trials for Carpal Tunnel Syndrome

The Relationship Between Ultrasonographic Findings and Sleep Quality in Carpal Tunnel Syndrome

Start date: February 23, 2023
Phase:
Study type: Observational

The aim of our study is to determine the relationship between disease severity and sleep quality in CTS patients and to compare the findings with healthy controls.

NCT ID: NCT05742633 Completed - Piriformis Syndrome Clinical Trials

Comparative Effect of Active Release Technique Versus Self-myofascial Release in Improving Piriformis Syndrome

Start date: February 3, 2023
Phase: N/A
Study type: Interventional

The goal of this Randomized controlled trial is to examine comparative effect of active release technique versus self-myofascial release in improving piriformis syndrome. The main question it aims to answer is: • To compare the effects of Active release technique (ART) and Self-Myofascial release (SMFR) on pain intensity, hip internal rotation and functional disability in patients with piriformis syndrome. Participants will be a given consent form and after subjects read and sign the informed consent, they would be included in study according to eligibility criteria. 2 groups would be included in study, Active release technique will be applied on group A by the physiotherapist and self-myofascial release will be applied on group B by the patients themselves through the use of foam-rollers and massage ball to compare the results of both these techniques on reducing pain, improving range and functional disability among individuals with piriformis syndrome. We will measure outcome through different outcome measure tools.

NCT ID: NCT05741112 Recruiting - Long COVID Clinical Trials

The Long COVID-19 Wearable Device Study

Start date: November 16, 2023
Phase: N/A
Study type: Interventional

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

NCT ID: NCT05740761 Recruiting - Rett Syndrome Clinical Trials

Gene Editing as a Therapeutic Approach for Rett Syndrome

MECPer-3D
Start date: March 1, 2021
Phase:
Study type: Observational

We designed the project to validate CRISPR/Cas9-based gene editing combined with AAV-based delivery for correction of the most common MECP2 mutations both in vitro and in vivo.

NCT ID: NCT05740319 Recruiting - Clinical trials for Irritable Bowel Syndrome

Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

Start date: June 10, 2023
Phase: N/A
Study type: Interventional

Participants will be given FMT through oral capsules or nasojejunal tube once a month. After three-time treatment, participants were followed up for three months. Participants complete specific scales to assess improvement in symptoms, emotion and quality of life. Besides, they report adverse effects and collect fecal samples at each visit.

NCT ID: NCT05740306 Enrolling by invitation - Clinical trials for Irritable Bowel Syndrome

Irritable Bowel Syndrome Overlaping Celiac Disease

IBSonCD
Start date: January 22, 2023
Phase:
Study type: Observational

The goal of this prospective observational cohort stuty is to assess the prevalence of overlap irritable bowel syndrome on coeliac disease in patients on gluten-free diet. The main questions it aims to answer are: - percentage of the occurrence of irritable bowel syndrome in the population of Polish patients with celiac disease on restrictive gluten-free diet - what is the correlation between the persistence of intestinal symptoms and adherence to a gluten-free diet (according to the patient's assessment) or confirmation of disease remission (based on histopathology or antibody level).

NCT ID: NCT05740046 Completed - Down Syndrome Clinical Trials

Motor Intervention Whit the Intorus Tool on Children With Down Syndrome

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test in people with down syndrome how does the INTORUS tool influence their psychomotor development. The main question it aims to answer is: - Does the INTORUS tool improve psychomotor development in people with Down Syndrome? The intervention program will be carried out during the Functional Habilitation sessions and will be carried out by the center's professionals. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the user attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs. Each session will consist of several exercises with their corresponding rest breaks described in the Intervention Protocol. Each session attendance will be recorded following an attendance record model created for the occasion. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the psychomotor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the psychomotor level with the INTORUS device. Randomization will be carried out using the Oxford Minimization and Randomization software.